Mark Schreuder

Mark Schreuder is a T1/T2 Research Fellow in the field of cancer biology. Mark is researching cancer-associated thrombosis by utilising blood samples to identify the role of procoagulant platelets.
ROLE
  • T1/T2 Research Fellow

Background:   

Mark Schreuder is working at the CTC as a T1/T2 Research Fellow in the field of cancer biology. During his training he gained extensive experience in cardiovascular research and biochemistry and with his work he aims to bridge the gap between the bedside and the lab bench. At the CTC, Mark is researching cancer-associated thrombosis by utilising blood from Sydney Catalyst's Embedding Research (and Evidence) in Cancer Healthcare study to identify the role of procoagulant platelets.

Mark has previously worked at the Experimental Cardiology department at Utrecht University and in the laboratory of Dr Andrew Hoy at the Sydney School of Medical Sciences. At the moment, Mark is completing his PhD in the laboratory of Dr Mettine Bos at the Leiden University in The Netherlands where he unravelled the mechanisms by which specialized coagulation proteins found in the venom of the Australian Eastern brown snake exert their extreme effects on blood clotting.

In his spare time, Mark enjoys baking and discovering Sydney's hotspots.

Research Interests: 

Mark's research interests include lung, prostate and pancreatic cancers.